Abstract
As iron ions may participate in the pathogenesis of cancer and viral infections, the aim of this study was to monitor their influence on proliferation, E6 and E7 oncogene expression and reactive oxygen species (ROS) production in two human papilloma virus (HPV) positive cervical carcinoma cell lines (HeLa and SiHa) and one HPV negative vulvar cell line (A431). The anti-anaemic drug, ferric–sorbitol–citric acid complex (FSC) as a source of Fe III ions was used. Cells were treated with FSC at the concentrations between 0.001 and 1 mM Fe III for different time periods. Fe III ions inhibited the viability of HeLa and A431 cells while it had no influence on SiHa cells. Furthermore, Fe III treatment showed a time-dependent and a higher stimulatory effect on E6/E7 expression in SiHa cells than in HeLa cells. Fe III ion treatment with concentrations lower than 0.1 mM showed a time and a concentration dependent intracellular ROS production in all tested cell lines, while the treatment with 1 mM concentration decreased ROS production in all tested cell lines. In conclusion, Fe III ion treatment apart from having an anti-tumour effect, as we previously described, enhances survival of HPV 16-positive cells and might be associated with HPV oncogenesis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
